Home LiteratureArticle Details
PMID: 7831531 Published · ppublish English Journal Article

The classification of ductal carcinoma in situ and its association with biological markers.

Seminars in diagnostic pathology ·Vol. 11 ·No. 3 ·1994-08-00 ·Pages 199-207

Bobrow LG, Happerfield LC, Gregory WM, Springall RD, Millis RR

Abstract

One hundred five cases of pure ductal carcinoma in situ (DCIS) seen in the Guys Hospital breast unit between 1975 and 1991 were reviewed and reclassified using a modified histologic classification based on cytological features as well as histological architecture. The expression of p53 protein, cerbB2 protein, progesterone receptor, and a proliferation antigen KiS1, all factors reported to be of prognostic significance in invasive ductal carcinoma, was also evaluated using immunohistochemical methods. The mode of presentation of these cases was noted, and its relationship to biological markers and histologic type was also assessed. Good interobserver agreement was achieved by two independent observers using the modified histologic classification. Strong correlation was seen between histologic pattern and biological markers as well as between the individual markers. Poorly differentiated DCIS was associated with a high proliferation rate, the presence of cerbB2 and p53 protein and the absence of progesterone receptors. Well-differentiated DCIS showed the reverse, and the intermediate group showed an intermediate pattern. Paget's disease of the nipple was only seen in association with poorly differentiated DCIS, but no other significant association was noted between mode of presentation and DCIS type.

MeSH Terms
Adult Aged Aged, 80 and over Antibodies, Monoclonal Antigens, Neoplasm/analysis Biomarkers, Tumor/analysis Breast Neoplasms/chemistry,classification Carcinoma in Situ/chemistry,classification Carcinoma, Intraductal, Noninfiltrating/chemistry,classification DNA Topoisomerases, Type II DNA-Binding Proteins Humans Immunoenzyme Techniques Middle Aged Nuclear Proteins/analysis Poly-ADP-Ribose Binding Proteins Receptor, ErbB-2/analysis Receptors, Progesterone/analysis Tumor Suppressor Protein p53/analysis
Chemicals
Antibodies, Monoclonal Antigens, Neoplasm Biomarkers, Tumor DNA-Binding Proteins Nuclear Proteins Poly-ADP-Ribose Binding Proteins Receptors, Progesterone Tumor Suppressor Protein p53 Receptor, ErbB-2 DNA Topoisomerases, Type II TOP2A protein, human
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Bobrow L G
Clinical Oncology Unit, Guy's Hospital, London, England.
Happerfield L C
Gregory W M
Springall R D
Millis R R
Article Info
Journal
Seminars in diagnostic pathology
Abbr.
Semin Diagn Pathol
ISSN
0740-2570
Published
1994-08-00
Pages
199-207
Language
English
Region
United States
NLM ID
8502262
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com